What Brought JM Smucker Down Despite Q4 Earnings Beat

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What Brought JM Smucker Down Despite Q4 Earnings Beat

© mphillips007 / Getty Images

J.M. Smucker Co. (NYSE: SJM | SJM Price Prediction) reported its fiscal fourth-quarter financial results before the markets opened on Thursday. The packaged foods company said that it had $2.57 in earnings per share (EPS) and $2.09 billion in revenue, which compares with consensus estimates of $2.29 in EPS and $2.06 billion in revenue. The same period of last year reportedly had $2.08 in EPS and $1.9 billion in revenue.

[in-text-ad]

During the quarter, net sales increased 10%, driven by an 11 percentage point contribution from higher volume/mix across the majority of categories and brands in the U.S. Retail Consumer Foods, U.S. Retail Coffee and U.S. Retail Pet Foods segments. Lower net price realization, primarily for coffee, reduced net sales by 1 percentage point.

Before the COVID-19 pandemic, fourth-quarter performance was trending in-line with the firm’s previous guidance expectations. Stay-at-home orders implemented during the quarter resulted in a significant increase in consumer demand across the firm’s retail businesses and a significant decline for its Away From Home business.

[nativounit]

In terms of its segments, the company reported as follows:

  • U.S. Retail Coffee net sales increased by 11% to $55.3 million.
  • U.S. Retail Consumer Foods net sales increased 22% to $89.9 million.
  • International and Away From Home net sales increased to $262.1 million.

Looking ahead to the 2021 fiscal full year, the company expects to see net sales decreasing in the range of 1% to 2% and EPS in the range of $7.90 to $8.30. Consensus estimates are calling for $8.43 in EPS and $7.7 billion in revenue for the year.

J.M. Smucker stock traded down less than 2% early Thursday at $112.58, in a 52-week range of $91.88 to $125.62. The consensus price target is $114.54.

[recirclink id=710919][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618